Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Transport Infrastructure Group Before Discussing R&D Site Strategic Factors in Magny-les-Hameaux | Frédéric Gardès - CEO of Colas Group
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Frédéric Gardès is the CEO of Colas Group
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Madryn Asset Management is a leading alternative asset management firm that invests in innovative healthcare companies specializing in unique and transformative products, technologies, and services. The firm draws on its extensive and diverse experience s
00:10:00
Investing in India's Growth Story: Insights from Amar Kalkundrikar of Nippon India Mutual Fund | Amar Kalkundrikar - Fund Manager, Nippon India Mutual Fund
00:10:00
Overview of Aurvana's Operations, Turnaround Strategy, and Financial Outlook
00:10:00
Why Choose Dunn Capital Management?
00:10:00
Inspiring Conversations: Gale Force Wins Podcast| Matt Adams - CEO of NetBenefit Software
00:10:00
Deciphering the Strategic Landscape of Global Economies and Investments | Strauss Zelnick, Founder, Zelnick Media Capital.
00:00:00
Why Mayo Clinic for Cancer Treatment - Mayo Clinic/ Sameer R. Keole, M.D. Radiation Oncologist, mayo Clinic
00:10:00
Terry Topping Unveils Kairos Minerals' Gold and Lithium Prospects in the Pilbara
00:10:00
Josh Wolfe of Lux Capital Discusses Cutting-Edge Technology and Defense Innovation | Josh Wolfe, Co-Founder, Lux Capital .
00:10:00
Nick Grant, President and CEO of inTEST Corporation, delves into the company's transformation, growth markets, and future initiatives during an interview on NYSE Floor Talk with Judy Shaw.|Nick Grant, President and CEO of inTEST Corporation
00:10:00
A Deep Dive into Real Estate Branding and Talent Development | Scott Durkin , CEO ,Douglas Elliman Inc.
00:10:00
Unlocking Revenue and Digital Success: Shueisha's Cxense Strategy Revealed! | Christian Printzell Halvorsen, Chief Executive Officer at Cxense ASA.